ANZGOG Annual Report 2016
- Update on performance against strategic goals
- 2016 ANZGOG highlights
- Latest trial information
WOMEN’S CANCER FOUNDATION AMALGAMATION WITH ANZGOG
On 1 January 2017, the Women’s Cancer Foundation and their sister organisation, Ovarian Cancer Institute, amalgamated with ANZGOG (Australia New Zealand Gynaecological Oncology Group).
This amalgamation will further grow the funds available for important research to help improve the lives of women with gynaecological cancers.
Over the last 20 years, Women’s Cancer Foundation (WCF) and the Ovarian Cancer Institute have made a significant contribution to research into ovarian cancer and other gynaecological cancers through their fundraising activities. This has included supporting gynaecological cancer research nurses at trial sites and other research projects.
Outstanding fundraisers for WCF for many years have been prior ANZGOG Chair, Professor Michael Quinn, AM and Duncan McPherson, OAM, along with many generous donors and bequestors.
Kerri Coghlan, Women’s Cancer Foundation Chair and Directors Orla McNally and Deborah Neesham commented: “ We are confident entrusting the future of our work to ANZGOG and they are honoured to accept the responsibility to continue to grow Women’s Cancer Foundation with your continued support.”
Alison Brand, ANZGOG Chair, said: ‘We are honoured to accept the responsibility to operate these fundraising programs cooperatively with ANZGOG’s research work. We are confident that this amalgamation will help maximise the efforts of both organisations, reduce overheads and expand fundraising nationally, with the result that greater funds will be available for research and other related projects.
Contact Alison.Evans@anzgog.org.au for further information.